Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-11-25Clinical Trial Update: Arsenic Trioxide in Treating Patients With Advanced Neuroblastoma or Other Childhood Solid Tumors [Phase 2]
Arsenic trioxide was studied in a Phase 2 trial for children with advanced neuroblastoma and other childhood solid tumors; results have been…
-
FDA approval · 2015-11-17FDA Approved: TOPOTECAN HYDROCHLORIDE — Supplemental Application (Accord Healthcare, Inc.)
FDA approved Accord Healthcare's supplemental application for Topotecan hydrochloride, enabling a generic version of the cancer drug to be m…
-
CLINICAL_TRIALS trial_result · 2015-11-06Clinical Trial Update: Palliative Care During Intraperitoneal Chemotherapy in Patients With Ovarian Cancer
This completed clinical trial evaluated palliative care during intraperitoneal chemotherapy in patients with ovarian cancer.
-
CLINICAL_TRIALS trial_result · 2015-10-27Clinical Trial Update: Sunitinib in Treating Patients With Metastatic Germ Cell Tumors That Have Relapsed or Not Responded to Treatment [Phase 2]
Phase 2 trial evaluating sunitinib for metastatic germ cell tumors that relapsed or were refractory to prior treatment; the study completed …
-
CLINICAL_TRIALS trial_result · 2015-10-26Clinical Trial Update: S0200 Carboplatin With or Without Doxil in Patients With Recurrent Ovarian Cancer [Phase 3]
A Phase 3 study (SWOG S0200) comparing carboplatin with or without Doxil in recurrent ovarian cancer has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-10-20Clinical Trial Update: A Clinical Trial to Determine the Most Suitable Dose of OPB-111001 in Patients With Advanced Cancer [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating OPB-111001 in multiple advanced cancers has been terminated.
-
CLINICAL_TRIALS trial_result · 2015-10-20Clinical Trial Update: Treatment of Relapsed and/or Chemotherapy Refractory Advanced Malignancies by CART-meso [Phase 1]
Phase 1 study of CART-meso, a mesothelin-targeted CAR-T cell therapy, in patients with relapsed or chemotherapy-refractory advanced cancers,…
-
CLINICAL_TRIALS trial_result · 2015-10-19Clinical Trial Update: Irinotecan and Bevacizumab for Recurrent Ovarian Cancer [Phase 2]
A Phase 2 study evaluating the combination of irinotecan and bevacizumab in recurrent ovarian cancer (including fallopian tube cancer and pr…
-
CLINICAL_TRIALS trial_result · 2015-10-14Clinical Trial Update: Study of AMG 386 in Combination With Paclitaxel and Carboplatin in Subjects With Ovarian Cancer [Phase 1]
Phase 1 study of trebananib (AMG 386) in combination with paclitaxel and carboplatin for ovarian cancer, fallopian tube cancer, and primary …
-
CLINICAL_TRIALS trial_result · 2015-10-12Clinical Trial Update: Use of Palliative Performance and Symptom Distress Scales in Older Patients With Advanced Ovarian Cancer
A clinical trial update on using the Palliative Performance Scale and Symptom Distress Scales in older patients with advanced ovarian cancer…
-
FDA approval · 2015-10-09FDA Approved: DOXORUBICIN HYDROCHLORIDE LIPOSOME — Supplemental Application (Baxter Healthcare Company)
FDA approved Baxter's supplemental NDA for doxorubicin hydrochloride liposome.
-
CLINICAL_TRIALS trial_result · 2015-10-09Clinical Trial Update: Stress Reduction in Improving Quality of Life in Patients With Recurrent Gynecologic or Breast Cancer [NA]
This completed clinical trial from Ohio State University Comprehensive Cancer Center evaluated whether stress-reduction interventions can im…
-
CLINICAL_TRIALS trial_result · 2015-10-09Clinical Trial Update: Disease Management Program or Usual Care in Patients With Stage III or Stage IV Lung Cancer, Pancreatic Cancer, Ovarian Cancer, or Colorectal Cancer, and Their Caregivers
This clinical trial update summarizes a completed study comparing a Disease Management Program to usual care for patients with stage III/IV …
-
CLINICAL_TRIALS withdrawal · 2015-10-08Clinical Trial Update: Celecoxib in Managing Pain, Weight Loss, and Weakness in Patients With Advanced Cancer [NA]
A clinical trial evaluating celecoxib for pain, weight loss, and weakness in advanced cancer has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2015-10-07Clinical Trial Update: Elizabeth Registry for Low Grade Ovarian Cancer
The Elizabeth Registry for Low Grade Ovarian Cancer, sponsored by M.D. Anderson Cancer Center, has completed its clinical registry study foc…
-
CLINICAL_TRIALS trial_result · 2015-09-29Clinical Trial Update: AMG386 Comb w. Either Pegylated Liposomal Doxorubicin or Topotecan Subjects w. Advanced Recurrent Epithelial Ovarian CR [Phase 1]
A Phase 1 trial evaluated AMG-386 in combination with either pegylated liposomal doxorubicin or topotecan in advanced recurrent epithelial o…
-
FDA approval · 2015-09-28FDA Approved: TOPOTECAN HYDROCHLORIDE — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for Topotecan Hydrochloride by Actavis Pharma, Inc., granting continued regulatory approval for this…
-
CLINICAL_TRIALS withdrawal · 2015-09-28Clinical Trial Update: Magnetic Resonance Imaging for Lymph Node Staging in Ovarian Cancer [Phase 4]
A Phase 4 clinical trial evaluating MRI for lymph node staging in ovarian cancer has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2015-09-28Clinical Trial Update: Docetaxel/Carboplatin Versus Docetaxel/Caelyx in Pretreated Patients With Ovarian Carcinoma [Phase 2]
Status update shows a Phase 2 randomized trial comparing docetaxel/carboplatin versus docetaxel/Caelyx in pretreated ovarian cancer patients…
-
CLINICAL_TRIALS trial_result · 2015-09-24Clinical Trial Update: Pilot Program to Personalize Care & Improve Quality of Life for Women With Ovarian Cancer [NA]
This clinical trial update reports the completion of a pilot program aimed at personalizing care for women with ovarian cancer. The program …
-
CLINICAL_TRIALS trial_result · 2015-09-23Clinical Trial Update: An RCT of Concurrent and Maintenance Cediranib in Women With Platinum-sensitive Relapsed Ovarian Cancer [Phase 3]
Phase 3 randomized trial of concurrent and maintenance cediranib in platinum-sensitive relapsed ovarian cancer; the current status is listed…
-
CLINICAL_TRIALS trial_result · 2015-08-25Clinical Trial Update: Panitumumab and Gemcitabine in Relapsed Ovarian Cancer [Phase 2]
Phase 2 trial evaluating the combination of panitumumab and gemcitabine in relapsed ovarian, fallopian tube, and primary peritoneal cancers …
-
CLINICAL_TRIALS research · 2015-08-17Clinical Trial Update: Prospective Identification and Validation of "BRCANess" Profile in Ovarian Epithelial Cancer
This clinical trial update outlines a prospective identification and validation of a BRCA-like (BRCAness) profile in ovarian epithelial canc…
-
CLINICAL_TRIALS trial_result · 2015-08-13Clinical Trial Update: BI 6727 (Volasertib) Randomised Trial in Ovarian Cancer [Phase 2]
Phase 2 randomized trial of volasertib (BI-6727) in ovarian cancer has completed and posted results. The study investigated volasertib in ov…
-
CLINICAL_TRIALS trial_result · 2015-08-05Clinical Trial Update: Chemotherapy Plus Surgery in Treating Patients With Stage III or Stage IV Ovarian, Peritoneal, or Fallopian Tube Cancer [Phase 3]
This Phase 3 trial evaluated chemotherapy plus surgery for patients with stage III or IV ovarian, fallopian tube, or primary peritoneal canc…